The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production
- 1 July 2000
- journal article
- case report
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 23 (7) , 473-475
- https://doi.org/10.1007/bf03343758
Abstract
We present a case of a patient suffering from metastatic differentiated thyroid carcinoma (DTC) and insufficient endogenous TSH production suspicious of secondary hypothyroidism. The use of recombinant human TSH (rhTSH) enabled us to administer a therapeutic activity of radioactive iodine (RAI) under maximal TSH-stimulation, achieving a marked decrease in thyroglobulin accompanied by a clinical improvement.Keywords
This publication has 10 references indexed in Scilit:
- Recombinant Human Thyrotropin in Thyroid Cancer and Hypopituitarism Due to Sella MetastasisThyroid®, 1999
- A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1Journal of Clinical Endocrinology & Metabolism, 1999
- Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): whole-body scanning with iodine-131.1999
- Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.1999
- Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid CarcinomaNew England Journal of Medicine, 1997
- Recombinant Human Thyrotropin Is a Potent Stimulator of Thyroid Function in Normal Subjects 1Journal of Clinical Endocrinology & Metabolism, 1997
- Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine131I and Recombinant Human Thyroid Stimulating HormoneJournal of Clinical Endocrinology & Metabolism, 1997
- Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism.Journal of Clinical Endocrinology & Metabolism, 1996
- Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).Journal of Clinical Endocrinology & Metabolism, 1994
- Thyroid carcinoma metastatic to pituitary.1985